Lobbying

Stonington Global's latest lobbying report covers Q3 2021, at $15K. Its first report covers Q4 2020; the issues it reports most are Health Issues and Medicare/Medicaid.

Stonington Global

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2020
The first quarter a report named it

Lobbying by quarter

Stonington Global lobbying by quarter
Stonington Global lobbying by quarter
QuarterAmountReports
Q4 2020$15K1
Q1 2021$15K1
Q2 2021$15K1
Q3 2021$15K1
Q4 2021$00
Q1 2022$00
Q2 2022$00
Q3 2022$00
Q4 2022$00
Q1 2023$00
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$22.5K · 3 reports
  • Medicare and Medicaid$22.5K · 3 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)3 reports
  • Health Resources & Services Administration (HRSA)3 reports
  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports

Firms it paid

Firm
Significant Consulting$60K4 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
23/10/18for Q3 2021Significant Consulting$15K
23/10/18for Q2 2021Significant Consulting$15K
23/10/18for Q1 2021Significant Consulting$15K
23/10/18for Q4 2020Significant Consulting$15K